New study tests enzyme replacement for rare genetic disease in chinese patients
NCT ID NCT05054387
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 29 times
Summary
This study tested the safety and effectiveness of Fabrazyme, an enzyme replacement therapy, in 22 Chinese patients with Fabry disease. Fabry disease is a rare genetic disorder that causes pain, organ damage, and other serious symptoms. Patients received Fabrazyme infusions for 54 weeks, and researchers monitored side effects and changes in disease markers. The goal was to see if this treatment is safe and helps control the disease in this specific population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FABRY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number :1560001
Shanghai, 200025, China
-
Investigational Site Number :1560002
Beijing, 100730, China
-
Investigational Site Number :1560003
Beijing, 100034, China
-
Investigational Site Number :1560004
Shanghai, 201102, China
-
Investigational Site Number :1560005
Wuhan, 016040, China
-
Investigational Site Number :1560006
Taiyuan, 030001, China
Conditions
Explore the condition pages connected to this study.